<DOC>
	<DOCNO>NCT01302691</DOCNO>
	<brief_summary>This study do evaluate efficacy , safety , tolerability losartan potassium 50 mg ( L50 ) + hydrochlorothiazide 12.5 mg ( H12.5 ) + amlodipine besylate 5 mg ( A5 ) ( MK-0954E ) . The primary hypothesis L50/H12.5/A5 effective lower mean trough sit diastolic blood pressure ( SiDBP ) 8 week treatment compare L50+A5 Japanese participant essential hypertension adequately control follow 8-week treatment filter period study drug ( L50+A5 ) .</brief_summary>
	<brief_title>MK-0954E Study Participants With Hypertension ( MK-0954E-357 )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion criterion Participant diagnosis essential hypertension . Participant treat single dual treatment hypertension able discontinue prior antihypertensive medication . Participant mean trough SiDBP ≥ 90 mmHg &lt; 110 mmHg . Participant mean trough SiSBP ≥ 140 mmHg &lt; 200 mmHg . Participant clinically significant abnormality screen visit . Exclusion criterion Participant currently take &gt; 2 antihypertensive medication . Participant history significant multiple and/or severe allergy ingredient NuLotan Preminent , amlodipine dihydropyridine drug , thiazide drug relate drug ( i.e. , sulfonamidecontaining `` chlortalidone '' medicine ) . Participant , time signing informed consent , user recreational illicit drug recent history within last year drug alcohol abuse dependence . Participant pregnant breastfeeding , expect conceive OR pregnancy test positive screening visit ( Visit 1 ) . Participant currently participate participate study investigational compound device within 30 day sign informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Essential hypertension</keyword>
	<keyword>Uncontrolled hypertension</keyword>
	<keyword>Antihypertensive agent</keyword>
	<keyword>Blood pressure</keyword>
</DOC>